V V Rameev Selected Research

VAD protocol

1/2003

[Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V V Rameev Research Topics

Disease

5	Immunoglobulin Light-chain Amyloidosis 01/2015 - 01/2003
4	Amyloidosis 01/2016 - 01/2006
4	Inflammation (Inflammations) 01/2016 - 11/2004
3	Rheumatoid Arthritis 01/2011 - 01/2003
2	Paraproteinemias (Monoclonal Gammopathy) 09/2020 - 07/2020
2	Fever (Fevers) 01/2017 - 01/2016
2	Cryopyrin-Associated Periodic Syndromes 01/2012 - 01/2002
2	Proteinuria 01/2006 - 11/2004
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Familial Mediterranean Fever (Periodic Disease) 01/2016
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Kidney Diseases (Kidney Disease) 01/2016
1	Disease Progression 01/2013
1	Essential Hypertension 01/2011
1	Joint Diseases (Joint Disease) 01/2011
1	Renal Insufficiency (Renal Failure) 11/2004
1	Arthralgia (Joint Pain) 01/2003
1	Multiple Myeloma 01/2003

Drug/Important Bio-Agent (IBA)

6	AA amyloidosisIBA 01/2017 - 01/2002
4	Amyloid (Amyloid Fibrils)IBA 07/2020 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2011
2	Immunoglobulins (Immunoglobulin)IBA 07/2020 - 01/2011
2	Interleukin-1 (Interleukin 1)IBA 01/2017 - 01/2012
1	S100A12 ProteinIBA 01/2016
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Calcium-Binding ProteinsIBA 01/2016
1	Bortezomib (Velcade)FDA Link 01/2016
1	Amyloidogenic ProteinsIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	ametantrone (HAQ)IBA 01/2011
1	Protein PrecursorsIBA 01/2011
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2010
1	Peroxidase (Myeloperoxidase)IBA 01/2006
1	Monoclonal AntibodiesIBA 01/2006
1	ChemokinesIBA 11/2004
1	Fibronectins (Fibronectin)IBA 11/2004
1	C-Reactive ProteinIBA 01/2003
1	AntibodiesIBA 01/2003
1	ArtrofoonIBA 01/2003
1	Rheumatoid FactorIBA 01/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003

Therapy/Procedure

4	Therapeutics 09/2020 - 01/2003
1	Aftercare (After-Treatment) 01/2003
1	VAD protocol 01/2003